Aurobindo Pharma reported INR10.94B in EBIT for its fiscal quarter ending in June of 2025.


Ebit Change Date
Cipla INR 15.25B 2.97B Jun/2025
Divis Laboratories Ltd 6.17B 2.48B Jun/2025
Dr.Reddys Laboratories INR 19.88B 4.44B Jun/2025
Hindustan Unilever INR 33.57B 530M Jun/2025
Sun Pharmaceuticals INR 32.48B 1.95B Jun/2025
UPL INR 5.46B 19.4B Jun/2025